ImmunoScape presented compelling new preclinical data at the American Association for Cancer Research (AACR) Annual Meeting 2026.
First-in-primate data demonstrate in vivo generation of genomic site-specific engineered TRAC-CAR T cells following a single intravenous ...
Presentations highlight AI-driven mRNA design process enabling up to 40-fold selectivity and 10-fold in vivo oncoselectivity ...
When the body encounters infection or cancer, cytotoxic T lymphocytes attach to the affected cell and form the immune synapse ...
Manufacturing CAR T cell therapy—one of the most powerful weapons against certain blood cancers—has to date involved an elaborate process, through which doctors first extract a patient’s immune cells ...
Phase II Trial of Nivolumab Plus Doxorubicin, Vinblastine, Dacarbazine as Frontline Therapy in Older Adults With Hodgkin Lymphoma Colorectal cancer (CRC) remains a major global health burden, being ...
Organ transplantation remains the cornerstone treatment for end-stage organ failure. While conventional broad-spectrum immunosuppression effectively controls acute rejection, it fails to address ...
How reorganizing existing drugs and vaccine components can dramatically alter their potency, selectivity, and even their ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results